Filippos Michopoulos
AstraZeneca (Japan)(JP)
Publications by Year
Research Areas
Metabolomics and Mass Spectrometry Studies, Cancer, Hypoxia, and Metabolism, Analytical Chemistry and Chromatography, CRISPR and Genetic Engineering, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Global metabolic profiling of animal and human tissues via UPLC-MS(2012)1,475 cited
- → Inhibition of Monocarboxylate Transporter-1 (MCT1) by AZD3965 Enhances Radiosensitivity by Reducing Lactate Transport(2014)188 cited
- → UPLC-MS-Based Analysis of Human Plasma for Metabonomics Using Solvent Precipitation or Solid Phase Extraction(2009)177 cited
- → Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt’s lymphoma anti-tumor activity(2017)150 cited
- → Classification of Ilex Species Based on Metabolomic Fingerprinting Using Nuclear Magnetic Resonance and Multivariate Data Analysis(2005)102 cited
- → Targeted profiling of polar intracellular metabolites using ion-pair-high performance liquid chromatography and -ultra high performance liquid chromatography coupled to tandem mass spectrometry: Applications to serum, urine and tissue extracts(2014)91 cited
- → Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance(2022)82 cited
- → Metabolomic Profile in HFpEF vs HFrEF Patients(2020)80 cited
- → Quantitation of Endogenous Metabolites in Mouse Tumors Using Mass-Spectrometry Imaging(2018)74 cited
- → Metabolite Profiles from Dried Biofluid Spots for Metabonomic Studies using UPLC Combined with oaToF-MS(2010)68 cited